Center for International Health, University of Bergen, Bergen, Norway
Search for other papers by Kjersti S Bakken in
Google Scholar
PubMed
Department of Microbiology, Innlandet Hospital Trust, Lillehammer, Norway
Search for other papers by Kristina Randjelovic Nermo in
Google Scholar
PubMed
Department of Clinical Science, University of Bergen, Bergen, Norway
Search for other papers by Bjørn Gunnar Nedrebø in
Google Scholar
PubMed
Search for other papers by Tim I M Korevaar in
Google Scholar
PubMed
Department of Research, Innlandet Hospital Trust, Lillehammer, Norway
Search for other papers by Tor A Strand in
Google Scholar
PubMed
criteria and indications for antithyroid drug treatments for Graves’ hyperthyroidism have remained essentially unchanged. A Norwegian government report from 1999 raised concerns regarding thyroid function in pregnancy and highlighted the need for data on
Search for other papers by Caiyan Mo in
Google Scholar
PubMed
Search for other papers by Tao Tong in
Google Scholar
PubMed
Search for other papers by Ying Guo in
Google Scholar
PubMed
Search for other papers by Zheng Li in
Google Scholar
PubMed
Search for other papers by Liyong Zhong in
Google Scholar
PubMed
.34 ATD, TSS 1.91 582 2.53 90.18 0.077 6.57 9.53 − ATD, antithyroid drugs; BMI, body mass index; Dmax, maximum diameter; F, female; FT3, free triiodothyronine; FT4, free thyroxine;GH, growth hormone; IGF-1, insulin-like growth
Search for other papers by Xiaowen Zhang in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Drum Tower Clinical Medical College, Southeast University, Nanjing, China
Search for other papers by Chen Han in
Google Scholar
PubMed
Search for other papers by Hongwei Wang in
Google Scholar
PubMed
Search for other papers by Xinghong Sun in
Google Scholar
PubMed
Search for other papers by Xin Dou in
Google Scholar
PubMed
Search for other papers by Xueying He in
Google Scholar
PubMed
Search for other papers by Di Wu in
Google Scholar
PubMed
Search for other papers by Shanmei Shen in
Google Scholar
PubMed
Search for other papers by Dalong Zhu in
Google Scholar
PubMed
Search for other papers by Xinlin Zhang in
Google Scholar
PubMed
Search for other papers by Yan Bi in
Google Scholar
PubMed
indicator of systemic inflammation. NLR has been reported to be associated with clinical prognosis in multiple disease contexts, including thyroid diseases ( 8 , 9 ). NLR predicts relapse in GD patients following antithyroid drug therapy ( 10 ) and disease
Search for other papers by Danzhou Fang in
Google Scholar
PubMed
Search for other papers by Shiying Li in
Google Scholar
PubMed
Search for other papers by Changgu Zhou in
Google Scholar
PubMed
Search for other papers by Yirui Wang in
Google Scholar
PubMed
Search for other papers by Gengbiao Yuan in
Google Scholar
PubMed
Search for other papers by HuiHui Zhang in
Google Scholar
PubMed
Search for other papers by Maohua Rao in
Google Scholar
PubMed
. Contemporary hyperthyroidism treatments encompass thyroidectomy, antithyroid drugs, and radioactive iodine ( 131 I) therapy ( 7 ). However, for those with hyperthyroidism and concomitant liver failure, surgery may not be feasible due to the requirement of near
Search for other papers by Yuegui Wang in
Google Scholar
PubMed
Search for other papers by Liwei Hong in
Google Scholar
PubMed
School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
Search for other papers by Caiyun Yang in
Google Scholar
PubMed
Quanzhou Medical College, Quanzhou, Fujian, China
Search for other papers by Guorong Lv in
Google Scholar
PubMed
Search for other papers by Kangjian Wang in
Google Scholar
PubMed
Search for other papers by Xuepeng Huang in
Google Scholar
PubMed
Search for other papers by Haolin Shen in
Google Scholar
PubMed
orbitopathy ( 5 ). Therapies for GD include antithyroid drugs (ATDs), thyroidectomy, or radioactive iodine (RAI) therapy. ATD has only a 50% success rate for most patients after 1 year of treatment, and it may cause side effects such as agranulocytosis
Search for other papers by Lian Duan in
Google Scholar
PubMed
Search for other papers by Han-Yu Zhang in
Google Scholar
PubMed
Search for other papers by Min Lv in
Google Scholar
PubMed
Search for other papers by Han Zhang in
Google Scholar
PubMed
Search for other papers by Yao Chen in
Google Scholar
PubMed
Search for other papers by Ting Wang in
Google Scholar
PubMed
Search for other papers by Yan Li in
Google Scholar
PubMed
Search for other papers by Yan Wu in
Google Scholar
PubMed
Search for other papers by Junfeng Li in
Google Scholar
PubMed
Search for other papers by Kefeng Li in
Google Scholar
PubMed
per 100,000 individuals per year ( 3 , 4 ). Current treatment for GD patients includes antithyroid drugs (ATDs), radioiodine therapy ( 131 I therapy) (RAI), and thyroidectomy ( 5 ). ATDs tend to have a higher failure rate. In addition, approximately
Search for other papers by Qian Yang in
Google Scholar
PubMed
Search for other papers by Wencai Ke in
Google Scholar
PubMed
Search for other papers by Fanfan Pan in
Google Scholar
PubMed
Search for other papers by Xinmei Huang in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
Search for other papers by Bingbing Zha in
Google Scholar
PubMed
step in thyroid hormone synthesis. Methimazole (MMI) is an established first-line therapy for GD in China and MMI-induced granulocytosis is dose-dependent ( 4 ). Antithyroid drug (ATD)-associated agranulocytosis is a rare but life-threatening event
Search for other papers by Waleed K W Al-Badri in
Google Scholar
PubMed
Search for other papers by Hinke Marijke Jellema in
Google Scholar
PubMed
Search for other papers by Arnaud R G G Potvin in
Google Scholar
PubMed
Search for other papers by Ruth M A van Nispen in
Google Scholar
PubMed
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Search for other papers by Peerooz Saeed in
Google Scholar
PubMed
. ( https://doi.org/10.4103/1119-3077.100620 ) 44 Fukao A Takamatsu J Kubota S Miyauchi A & Hanafusa T . The thyroid function of Graves’ disease patients is aggravated by depressive personality during antithyroid drug treatment
Search for other papers by Ayse Nurcan Cebeci in
Google Scholar
PubMed
Search for other papers by Vera Schempp in
Google Scholar
PubMed
Search for other papers by Katharina Förtsch in
Google Scholar
PubMed
Search for other papers by Bettina Gohlke in
Google Scholar
PubMed
Search for other papers by Michaela Marx in
Google Scholar
PubMed
Search for other papers by Helmuth-Guenther Dörr in
Google Scholar
PubMed
Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
, antithyroid drug; BR, block and replace; C, carbimazole; D, dose titration; f, female; m, male; LT4, levothyroxine; M, methimazole. The clinical characteristics of children with GD and DS in comparison with GD children without DS are shown in Tables
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Search for other papers by Heleen I Jansen in
Google Scholar
PubMed
Search for other papers by Marijn M Bult in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Endocrinology and Metabolism, Amsterdam, The Netherlands
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Search for other papers by Jacquelien J Hillebrand in
Google Scholar
PubMed
, however, not investigate the use of other drugs, such as antithyroid drugs, beta-blockers, or glucocorticoids which could have influenced fT4 results as well and should ideally be looked at in future (prospective) studies ( 11 ). We found that an fT4